PFM Health Sciences’s Cemex CX Stock Holding History

PFM Health Sciences’s Portfolio CX Stock Details CX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-524,747	Closed	-$5.67M	–	68
2014 Q1	$5.67M	Buy	+524,747	New	+$5.66M	0.1%	66

Other funds holding CX

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

PFM Health Sciences's CX Position: Q2 2014 in Review

PFM Health Sciences sold out of Cemex (CX) in Q2 2014, closing a stake of 524,747 shares — an estimated $5.67M sold.

PFM Health Sciences first reported a position in CX in Q1 2014 and held it in 1 quarter. The position peaked at $5.67M in Q1 2014. 265 funds tracked by Wall St. Rank hold CX as of Q2 2014.

PFM Health Sciences reported no remaining Cemex position as of Q2 2014 after selling out during the quarter.
PFM Health Sciences sold 524,747 Cemex shares in Q2 2014, an estimated $5.67M.
PFM Health Sciences first reported a position in Cemex in Q1 2014 and held it in 1 quarter.
PFM Health Sciences's Cemex position peaked at $5.67M in Q1 2014.
265 funds tracked by Wall St. Rank held Cemex as of Q2 2014.

Based on PFM Health Sciences's 13F filing for Q2 2014, filed 14 Aug 2014.